Aytu BioPharma, Inc.
Balance Sheet
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $7.0M | $802.3K | $8.1M | $7.4M | $2.6M | $2.9M | — | — |
| Accounts Receivable | $578.8K | $528.0K | $162.4K | $157.1K | — | — | — | — |
| Inventory | $1.3M | $1.3M | $524.7K | $39.4K | — | — | — | — |
| Total Current Assets | $9.5M | $3.0M | $10.1M | $8.0M | $3.3M | $1.9K | $186 | $4.2K |
| Property, Plant & Equipment | $218.7K | $647.3K | $231.4K | $29.7K | $57.2K | $7.5K | $12.5K | $18.6K |
| Goodwill | — | $238.4K | $221.0K | $74.0K | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $245.9K | $271.3K | $296.6K | $628.8K | $699.6K | — | — | — |
| Total Assets | $21.1M | $15.0M | $24.3M | $18.2M | $12.0M | $9.7K | $12.6K | $22.8K |
| Liabilities | ||||||||
| Accounts Payable | $2.1M | $2.2M | $2.3M | $1.2M | $649.5K | $6.8K | $5.8K | $330 |
| Total Current Liabilities | $3.4M | $3.6M | $10.1M | $1.5M | $6.1M | $120.5K | $82.4K | $58.4K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $7.6M | $11.0M | $14.3M | $2.6M | $6.6M | $120.5K | $82.4K | $58.4K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-79.3M | $-69.1M | $-46.6M | $-18.4M | $-10.7M | $-500 | $-500 | $-500 |
| Total Stockholders' Equity | $13.4M | $4.0M | $10.1M | $15.6M | $5.4M | $-110.9K | $-69.7K | $-35.6K |